INTRODUCTION
In three‐dimensional (3D) bioprinting, biomaterials‐based bioinks are widely used to fabricate 3D tissue constructs (or tissue models) embedded with living cells for tissue engineering and disease modeling. Bioink goes beyond simply creating shapes, it must provide cell‐friendly environments and structural support for encapsulated cells to grow, interact, and remodel (Chen, 2025a). 3D bioprinting is a technique that leverages a computer‐aided design (CAD) model to fabricate in vivo‐like hierarchical cell structure (Chen, 2025b). The development of effective 3D microtissue models represents a significant advancement beyond the gold standard of two‐dimensional (2D) cell culture. While 2D culture systems have long served as a foundational tool in biomedical research (Ning et al., 2016), these systems fall short in replicating the complex cellular architecture, mechanical cues, and biochemical gradients often found in vivo. In contrast, 3D microtissue models offer enhanced physiological relevance with potential to reduce dependence on animal models.
Alginate‐based bioinks are distinguished by their rapid ionic gelation, tunable mechanical properties, shear thinning properties for printability, and ability to mimic the native extracellular matrix (ECM). It is a linear anionic polysaccharide extracted from brown seaweeds that can be smoothly extruded through bioprinter nozzles. Alginate undergoes rapid gelation in the presence of divalent cations such as calcium (Ca2+) to effectively preserve the printed geometry (Lee & Mooney, 2012). Despite its widespread use in engineering 3D tissue scaffolds, alginate has limited long‐term structural stability due to its naturally derived origin and inherently lacks cell adhesion binding sites and mechanical properties to maintain shape fidelity and promote tissue maturation. Often, alginate is blended with other active biomolecules to improve its printability, mechanical performance, and biological properties. There are a variety of other biocompatible materials, e.g., collagen, gelatin, and decellularized ECM, to enhance alginate biocompatibility and provide tissue‐specific cues that eventually improve cell infiltration and regeneration (Blanco‐Fernandez et al., 2022; Catoira et al., 2019; Jain et al., 2021; Wang et al., 2024; Yeleswarapu et al., 2023). Although alginate‐based bioprinting has been widely reported, detailed protocols for preparing alginate‐based bioinks and characterizing bioprinted constructs remain insufficiently documented. In our lab, we have been working extensively on developing reliable protocols for printing alginate‐based bioinks, addressing challenges including achieving precise print resolution and enhancing cell viability and recovery post‐printing (Dahlan et al., 2025; Ketabat et al., 2023; Mohabatpour et al., 2022; Sadeghianmaryan et al., 2022; Sarker et al., 2019; Zimmerling, Aubrey, et al., 2024; Zimmerling, Boire, et al., 2024; Zimmerling, Sunil, et al., 2024; Zimmerling, Zhou, et al., 2024).
The protocols in this article present a comprehensive workflow encompassing cell culture and expansion, alginate bioink preparation, scaffold or construct design and bioprinting, as well as post‐printing characterizations and data analysis, as illustrated in Figure 1. Basic Protocols 1 and 2 describe the culturing of representative cells, specifically human umbilical vein endothelial cells (HUVECs), along with the preparation of alginate‐based bioinks, and rheological characterization of bioinks. Basic Protocol 3 details the preparation for 3D printing and bioprinting process, including the selection or determination of printing parameters. To complement these steps, Support Protocol provides the preliminary printing parameter determination and fine‐tuning printing parameters. We recommend conducting preliminary tests with cell‐free hydrogel inks to screen candidates and optimizing the printing parameters or conditions before transitioning to cell‐laden bioinks. This approach facilitates troubleshooting and helps reduce material and cell‐related costs. Basic Protocol 4 present methods to assess printability, seed cells on printed constructs, conduct live/dead staining, and perform imaging and quantitative analysis using ImageJ software. We also include a modified immunostaining protocol tailored for cell‐laden hydrogel constructs.
Overview of the protocols. Basic Protocolcovers the cell culture/expansion and bioink preparation; Basic Protocoloutlines the characterization of bioink using rheology; Basic Protocolcovers the design and bioprinting of scaffolds/constructs; Basic Protocoldescribes the post‐printing characterization by printability, cell viability, and immunostaining assay. 1 2 3 4
BIOINK PREPARATION
This protocol provides step‐by‐step instructions for preparing an alginate‐based bioink. It also includes complete instructions for culturing HUVECs used as an adherent cell model. The protocol is organized into two sections:
NOTE: Always label the culture flask with the cell name, passage number, date, and your initials.
NOTE: Sterilize all materials, e.g., culture flasks, serological pipettes, pipette pump, with 70% ethanol before placing them in the biological safety cabinet (BSC).
NOTE: Cell‐related procedures must be conducted inside a BSC to prevent contamination and maintain a sterile working environment.
CAUTION: It is not recommended to warm the medium in a water bath, as this can cause some components to degrade. Alternatively, allow the medium come to room temperature naturally before use.
Materials
Culturing HUVECs for cell expansion
Seeding cells
HUVECs at () low and () high densities maintained in a T75 flask. A B
Changing medium
Passaging cells
Alginate‐based bioink preparation
Day 1: Hydrogel mix preparation
Fresh hydrogel mix must be prepared 1 day prior to bioprinting or rheological analyses to ensure appropriate cell viability, printability, and consistency in material properties. It is recommended to prepare the hydrogel mix at ∼70% higher concentration to account for subsequent dilution with the cell suspension in culture medium. For example, if the final desired concentration is 3% (w/v) alginate and 1% (w/v) gelatin, prepare the initial hydrogel at 4.28% (w/v) alginate and 1.43% (w/v) gelatin. Then, mix the hydrogel with the cell suspension (prepared in culture medium) in a 70:30 ratio to achieve the target final concentrations.
Day 2: Preparing cell‐laden bioink
BIOINK CHARACTERIZATION USING RHEOLOGY
This protocol provides a detailed guide for characterizing bioink candidates using rheological measurements. It outlines the procedures for conducting rheological tests to evaluate hydrogel properties, including shear‐thinning behavior and viscosity. The protocol is divided into two sections:
CAUTION: If the pressure is not set correctly, the bearing and instrument could be damaged. To prevent this, the regulator is attached to an alarm that visibly and audibly alerts the operator if the pressure is too low. Testing should be discontinued, or the backup pressure line should be opened if in the middle of a test.
Materials
Rheology
This protocol is based on our established work by Zimmerling, Sunil, et al. (2024) and Zimmerling, Zhou, et al. (2024).
Setting up the Discovery‐series HR 20
() Current HR 20 setup with the main components labeled. Not visible is the pressure regulator, which is behind the computer screen. () Front panel buttons of the main instrument. The most used buttons will be the Power, Toggle Light, Instrument Head Up/Down, and Bearing Lock buttons. A B
Software interface of TRIOS. () Go To Geometry Gap, () Go To Trim Gap, () Raise To Loading Gap, () Zero Gap, and () Zero Axial Force. A B C D E
Setting up the rheological experiments
SCAFFOLD DESIGN AND BIOPRINTING
This protocol describes the complete workflow for preparing printing solutions and bioprinting tissue constructs. It includes the key steps for evaluating print quality and supporting cell‐recovery post‐printing. The protocol is organized into four main sections as follows:
NOTE: Tapered dispensing needle tips are preferred for bioprinting because their design minimizes the shear stress experienced by encapsulated cells.
NOTE: PEI coating can have adverse effects on cell morphology, often causing them to remain round and inhibiting proper spreading. For constructs that retain their structure post‐printing, it is recommended to transfer the constructs to a new well plate without PEI coating for further culture to avoid these negative effects on cell behavior.
CAUTION: Printing parameter determination can be conducted with cell‐free solutions if using low density cell incorporation. For high density cell incorporation, it is recommended to determine parameters with a cell‐laden bioink solution.
CAUTION: When printing with cells do not exceed an extrusion pressure of 25 kPa to avoid cell damage.
CAUTION: Rinsing is important to remove residual crosslinking agents and unreacted components using suitable buffer/saline solutions. For example, sterile 1× PBS can be used if the construct materials are not sensitive to phosphate ions.
Materials
Day 1: Preparing printing solutions
Preparation of PEI solution for coating the culture plates
Polyethyleneimine (PEI) is applied as a coating on the culture plates for 3D‐printing alginate scaffolds to improve the adhesion of alginate filaments to the culture plate during printing (Mendoza García et al., 2017). This effect arises from the negatively charged surface of alginate and the positively charged nature of PEI, which generate strong ionic interactions that enhance scaffold stability and attachment.
Preparation of printing solution containing PEI and calcium chloride
Day 2: Scaffold design and 3D printing
Demonstration of BioScaffold Printer 3.2 printer setup and 3D‐printing, related to Basic Protocol(steps 18‐30). 3
3D‐printing parameter determination
Example of printing parameter setup.
Post‐printing procedure
3D‐PRINTING PARAMETER DETERMINATION
Mathematical models of the printing process can assist in determining initial printing parameters, such as printing pressure and speed. We recommend using these models in parallel with the 3D‐printing process (Basic Protocol, steps 31 to 38) to fine‐tune these parameters and enhance reproducibility. Preliminary experiments can be conducted using the pressure and speed determined based on the models to ensure the width of the printed filaments closely matches the designed filament diameter. This step is critical because complex interactions between the printing solutions and the crosslinking mechanism, such as swelling and buoyancy, can alter the filament diameter, making it differ from the intended design. 3
NOTE: See Chen (2025a); Dahlan et al. (2025); Li et al. (2011); and Tabil et al. (2025).
Materials
As such, the printing speed is directly dependent on the printing pressure. Repeating the above for each operator‐set pressure will result in a list of printing pressures and corresponding printing speeds.
PRINTABILITY AND CELL VIABILITY ANALYSES, AND IMMUNOFLUORESCENCE ASSAY
This protocol outlines a step‐by‐step guide for assessing printability and seeding cells onto printed scaffolds. It also includes procedures for live/dead staining, imaging, and quantitative analysis using ImageJ software, as well as immunofluorescence assay for bioprinted constructs. The protocol is organized into five main sections as follows:
Materials
Printability analysis
See Naghieh and Chen (2021); Ning, Sun, et al. (2018); Soltan et al. (2019); Zimmerling, Aubrey, et al. (2024); and Zimmerling, Zhou, et al. (2024).
Example of () poor printability with thin strands, () desired printability, and () poor printability with thick strands. A B C
Equation 5 assumes square pore geometries.
Cell seeding
Cell viability staining
Determine the volume of solution required based on how many wells you are studying and the height of the cell‐laden constructs or cell‐seeded scaffolds. Typically, 0.5 ml per well is sufficient to fully cover constructs/scaffolds <1 mm in height.
Cell viability visualization
Cell viability quantification
Immunofluorescence assay on whole cell‐laden constructs or cell‐seeded scaffolds
Immunofluorescence assay on sliced cell‐seeded scaffolds
Cryosectioning: Slide coating
Tissue sectioning
Antibodies staining
REAGENTS AND SOLUTIONS
Blocking/permeabilization solution for IF
HUVEC complete cell culture medium
Live/Dead stain solution
Primary antibody cocktail for IF
Secondary antibody cocktail for IF
COMMENTARY
Critical Parameters
Cell passaging
It is important to maintain consistent cell passage numbers across all bioprinting experiments. Variation in cell passaging, especially primary cells can significantly affect cell growth rates, behavior, and response to post‐printing damage. Once printing and culture conditions are established, it is recommended to prepare sufficient stocks of cells at the same passage number to make sure all bioprinting experiments use cells with uniform passage history.
Cell density
Determine the cell density based on Live/Dead assay in Basic Protocoland make sure the cells are consistently distributed throughout the printed constructs. Cell overcrowding can lead to nutrient depletion, hypoxia, and increased cell death after long‐term culture. As mentioned before, use cells of the same passage number to reduce variability at the determined seeding density. 4
Bioprinting live cells
Ideally, bioink temperature should be maintained within a physiological or material‐specific range (20° to 25°C for most cell compatible hydrogels, or 37°C for thermo‐responsive materials like gelatin) to preserve cell viability and material consistency during printing. It is not recommended to print for an extended period (3 to 4 hr) as cell suspended in the bioinks experience continuous shear and pressure stress within the extrusion system. Instead, keep printing sessions as short as possible or perform printing in batches.
Troubleshooting
See Table 1 for a troubleshooting guide for the preparation and characterization of alginate‐based bioinks for 3D bioprinting of cell‐laden constructs.
| Protocol | Problem | Possible cause | Solution |
|---|---|---|---|
| Basic Protocol: Bioink preparation 1 | Bubbles in hydrogels after mixing with cells | Mixing process was too vigorous | Gently tap the syringe to dislodge bubbles and let it sit for ∼2 min to allow the bubbles to naturally rise to the top |
| Purging the materials for <10 s may help eliminate larger bubbles | |||
| Basic Protocol: Bioink characterization using rheology 2 | Rheological characterization results are not consistent and illogical trends of data are present | The sample is drying on the plate | Use a solvent trap |
| Too much stress was applied when transferring samples by using a spatula or pipette | Add more soak time, e.g., 5 min. Or apply a low constant pre‐shear (0.1‐1 s) to all samples and soak to ensure all samples start at similar conditions−1 | ||
| Flow sweep tests indicate a sharp drop‐off in stress or viscosity data as shear rate increases | The shear rate is too high, and the sample is being expelled from the testing area | Decrease both the lower and upper bounds of the applied shear rate | |
| Basic Protocol: Scaffold design and bioprinting 3 | Poor material attachment | Higher z‐offset | Recalibrate the cartridge dispenser on the printer and measure each well |
| Attempt to manually adjust the z‐offset lower until the needle lightly scratches the plate | |||
| The well plate was not properly coated with PEI | Ensure well plates are coated for a minimum of 24 hr prior to printing at 37°C | ||
| Material not extruding from the needle | Clogged needle due to material viscosity or cell clumping | Increase the extrusion pressure while gently cleaning the needle with a Kimwipe; if the material still does not extrude, replace the needle and recalibrate the cartridge dispenser | |
| To minimize bioink loss, place an autoclaved beaker or any container filled with autoclaved water beneath the needle, and submerge the needle in the water while gently purging the bioink using consistent pressure | |||
| Over‐extrusion or material dropping from the nozzle tip | Material viscosity/temperature issues (for temperature‐sensitive hydrogels) | Use rheology to evaluate the material viscosity | |
| Adjust printing parameters, i.e., speed, extrusion pressure, nozzle temperature | |||
| Consider using an external 0.2‐µm syringe filter instead of the cartridge barrel piston | |||
| The printing starts to fail once printing the last layers | The z‐offset or z‐offset action (the z‐offset between layers) needs to be adjusted | Increase the z‐offset or z‐offset action (you need to adjust the z‐offset if you change the z‐offset action) if the fibers of the first layer are too narrow | |
| Decrease the z‐offset if the fibers of the first layer are too wide | |||
| Ensure that the fiber width and height are equal; the recommended value for the z‐offset is twice the fiber height (or width) | |||
| Yellowing of medium in bioprinted construct culture | Acidification of medium, hypoxic environment or contamination by bacteria or fungus | Check pH of the hydrogel materials prior to adding cells using pH test strips | |
| Design scaffolds with appropriate porosity to improve circulation and nutrient movement | |||
| Ensure all surfaces are properly sterile using 70% ethanol or UV light | |||
| Basic Protocol: Printability and cell viability analyses, and immunofluorescence assay 4 | Low cell viability post‐printing | Filament thickness, printing pressure | While preparing the bioink, handle the cells gently during mixing |
| Try to minimize the printing time | |||
| Avoid storing the bioink for >3 hr | |||
| Lower printing pressure might induce reversible changes to cell damage | |||
| Increase supplementation (e.g., 2× FBS) to boost cell recovery | |||
| Screen cells with higher resistance to printing pressure to achieve the best results | |||
| Avoid keeping the constructs in the same printing plate due to the cytotoxicity of PEI | |||
| Wash the scaffolds thoroughly (e.g., with culture medium) for at least three times after crosslinking | |||
| Poor image quality | Some biomaterials may exhibit background autofluorescence that can interfere with imaging | Use scaffold‐only as a control to identify which filter causes interference | |
| Discard the staining medium and replace it with fresh medium | |||
| Use a confocal microscope instead of a standard fluorescence microscope for improved imaging resolution and depth | |||
| Poor signal | Thicker and denser scaffolds may require longer incubation times with the dye to ensure adequate penetration and staining | Increase the incubation time | |
| Incubate at room temperature |
Understanding Results
Rheology
The rheological properties of alginate‐based bioinks are influenced by factors, such as bioink concentration, cell density, and temperature. Using the rheological tests, as outlined in this protocol (via oscillation amplitude, flow sweep, and temperature ramp tests), one can iteratively tune and optimized bioink formulation for the high printing quality or fidelity and/or preserve cell survival. Figures 9A‐B show the storage and loss moduli, which indicate how “solid‐like” or how “liquid‐like” a bioink behaves, respectively. In oscillation amplitude tests, liquid‐like bioinks exhibit a dominant loss modulus, whereas solid‐like bioinks show a dominant storage modulus. These tests also give the information on loss angle (δ), with tan(δ) being the ratio of the loss modulus over the storage modulus. This ratio reflects the bioink ability to recover the deformation after force removal; tan(δ) <1 suggest that most deformation is recovered while tan(δ) >1 indicates that most deformation is permanent, manifesting as plastic deformation or flow. Bioink flow behavior or viscosity should be carefully adjusted to preserve the cell viability during the printing process, which can be achieved by modifying bioink composition or the cell density (Ning, Betancourt, et al., 2018). For example, Figure 9D show that adding both cells and collagen increase the viscosity of the alginate‐based bioink. Temperature also plays a critical role; as shown in Figure 9F, increasing temperature reduces viscosity. Overall, rheological tests simulate printing conditions and provide insights for refining bioink formulations to improve print quality and cell viability.
Examples of graphs and data typically received from rheological property characterization. Represented by orange and blue lines are the properties of previously printed biomaterial solutions, with and without cells. Panels (‐) show viscoelastic properties of the tested materials. Panels (‐) show the viscosity and shear stress response of the samples as the rate of shear increases. Panel () shows the viscosity profile of the samples as temperature changes at a constant, low shear rate. A C D E F
Printability
Printability of alginate‐based bioinks refers to its ability to form and maintain a 3D structure after printing and is essential for ensuring structural stability and supporting cellular functions. Printability of the bioink is dependent on rheological properties, which suggest the rheological behavior should be adjusted suitable for printing, as demonstrated in Figure 9. Scaffold design and printing parameters also influence printability and should be selected based on the intended application. Successfully fabricated scaffolds should demonstrate consistent filament deposition with interconnected pores and minimal breakages. Microscopic images as shown in Figure 8 combined with Equations 4 and 5 can be used to assess the filament diameter and pore sizes to determine printability. In addition to these quantitative measurements, factors including needle clogging, filament breakages, and printing consistency should be considered when determining printability. A filament printability value of 1 indicates the printed strands match the designed diameter; however, if this results in frequent breakages (as shown in Fig. 8A), a slightly larger value may be preferred for improved structural integrity. Similarly, a pore printability value of ∼1 is indicative of consistent pores with minimal irregularities and a stable structure. Notably, Equation 5 is only valid for square pore geometries, in cases where scaffolds have an angular design, printability may be assessed based on filament diameter and printing consistency.
Viability
Cell viability provides insight into the biocompatibility and functionality of the printed/bioprinted models. Fluorescent microscopy provides a visual representation of cell viability with live cells indicated by green fluorescence and dead cells shown in red fluorescence (Figs. 10 and 11). Subsequent analysis of these images with Fiji software provides a quantification of cell viability. Fluorescent images should indicate evenly distributed cells for both seeded and bioprinted cells as indicated by Figures 10 and 11. A recovery period after seeded cells is to be expected with later timepoints demonstrating enhanced viability as demonstrated by Figure 11. Bioprinted cells may demonstrate a similar trend or have more consistent viability across timepoints depending on cell type as shown in Figure 10 (Xu et al., 2022). Appropriate image analysis in Fiji software (Schindelin et al., 2012) is necessary to obtain an accurate quantification of viability. Correctly interpreted images used for viability quantification will demonstrate cells with clear boundaries, minimal noise, and few cells omitted. A viability of ≥70% can be achieved under appropriate conditions for 3D bioprinted constructs (Ning et al., 2021; Xu et al., 2022), and a viability of ∼90% is expected with cell‐seeded scaffolds (Ketabat et al., 2023; Ning et al., 2016).
Immunofluorescence
Immunofluorescence is an important tool for detecting and localizing specific antigens within cells and tissue samples using fluorescently‐labeled antibodies, providing insights into the functionality of cells within constructs. Immunofluorescence can be performed using either the direct method (primary antibody only) or the indirect method (secondary antibody) (Im et al., 2019). In this protocol, we provided instructions for the indirect method. Staining can be performed either on the entire construct without embedding and freezing, or on embedded, frozen samples that are sectioned prior to staining (Fig. 12). The former allows for more integrated 3D localization of antigens within the construct, as it avoids potential damage caused by freezing and sectioning. This method offers higher spatial resolution in three dimensions but is limited by the fact that each whole construct can be used for only one staining, making it relatively expensive and unsuitable for repeated or multiplexed analysis. In contrast, frozen and sectioned samples may experience some signal loss or tissue damage, and the resulting images are limited to 2D slices. However, this approach enables multiple sections from the same sample, allowing for replication and the analysis of various antigens across different regions of the construct.
Representative immunofluorescence images of single and dual staining on alginate/gelatin scaffolds. Panels (‐) correspond to whole‐mount staining of constructs laden with HUVECs and seeded with cardiomyocytes. Cardiac troponin T (cTnT) staining identifies cardiomyocytes, while CD31, a cell–cell adhesion marker, labels HUVECs. Panels (‐) show sectioned constructs containing only HUVECs, stained for CD31 and connexin 43 (Cx43), a gap junction marker. Whole‐mount images (‐) demonstrate improved resolution and more integrated spatial localization of both cardiac and endothelial markers compared to the sectioned constructs (‐), which exhibit reduced spatial continuity. Nevertheless, both approaches revealed a vascularized organization of endothelial cells, achieving the primary objective of the staining. A B C D A B C D
Time Considerations
Basic Protocol 1: Bioink preparation
Cell thawing and expansion should be initiated at least 1 week prior to bioprinting to ensure cells reach a healthy state. Hydrogel mix can be prepared 1 to 2 days in advance and stored at 4°C, but prolonged storage is not recommended to maintain consistency and reproducibility.
Basic Protocol 2: Bioink characterization using rheology
Running rheology typically takes 1 to 3 hr, depending on the number of samples.
Basic Protocol 3: Scaffold design and characterization
The printing solution and 0.1% (w/v) PEI coating of culture plates should be prepared 1 day before bioprinting. Cell‐laden bioink should be prepared within 1 hr before printing to preserve cell viability and function. It is recommended to bioprint within 3 to 4 hr per session to minimize cellular stress from prolonged shear exposure.
Basic Protocol 4: Printability and cell viability analyses, and immunofluorescence assay
The cell viability assay typically takes up to 1 hr, depending on the number of samples. For immunofluorescence staining, allow up to 2 days as this includes incubation with both primary and secondary antibodies.
Author Contributions
Nuraina Dahlan: Conceptualization; formal analysis; investigation; methodology; project administration; validation; writing—original draft. Farinaz Ketabat: Conceptualization; formal analysis; investigation; methodology; validation; writing—original draft. Kathryn Avery: Conceptualization; formal analysis; investigation; methodology; software; validation; writing—original draft. Xavier Tabil: Conceptualization; formal analysis; investigation; methodology; validation; writing—original draft. Samira Khoz: Conceptualization; methodology; writing—original draft. Elise Altarriba: Investigation. Neeraj Dhar: Funding acquisition; resources; supervision; validation; writing—review and editing. Xiongbiao Chen: Conceptualization; funding acquisition; resources; supervision; validation; writing—review and editing.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgments
N.A.D. was supported by the Living Skies Postdoctoral Fellowship of the University of Saskatchewan. The authors are also thankful to the Saskatchewan Health Research Foundation Solutions (SHRF) (SHRF‐6239; SHRF‐6698 and SHRF‐6185), and the Natural Sciences and Engineering Research Council of Canada (NSERC) (PGPIN 06396‐2019; RGPIN‐2023‐05746). Vaccine and Infectious Disease Organization (VIDO) receives operational funding from the Government of Saskatchewan through Innovation Saskatchewan and the Ministry of Agriculture and from the Canada Foundation for Innovation through the Major Science Initiatives.
Dahlan, N. A. , Ketabat, F. , Avery, K. , Tabil, X. L. , Khoz, S. , Altarriba, E. , Dhar, N. , & Chen, X. (2025). Preparation and characterization of alginate‐based bioinks for three‐dimensional bioprinting of cell‐laden constructs. Current Protocols, 5, e70290. doi: 10.1002/cpz1.70290
Contributor Information
Nuraina Anisa Dahlan, Email: nuraina.dahlan@usask.ca.
Xiongbiao Chen, Email: xbc719@mail.usask.ca.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Literature Cited
Associated Data
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.